MPO and Fabry disease: Mean plasmatic MPO concentration (SI Figure S10) was increased in FD patients compared to healthy controls (483.66 ± 86.30 ng/mL in controls and 1461.88 ± 214.64 ng/mL in FD patients: in naïve 1353.01 ± 365.65 ng/mL and in ERT-treated 1539.64 ± 262.42 ng/mL) and was significantly different in male patients versus female FD patients.